Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/69957

Type
Papers presented at events
Copyright
Open access
Collections
Share

Statistics
Metadata
Show full item record

DEVELOPMENT OF LIPOSOMES CONJUGATED TO ANTI-EGFR MONOCLONAL ANTIBODY FOR SELECTIVE DELIVERY OF OXALIPLATIN TO COLORECTAL CANCER CELLS
Moreira, Thais da Silva et al. | Date Issued: 2025
Author
Moreira, Thais da Silva
Marques, Letícia Paifer
Petrilli, Raquel
Eloy, Josimar de Oliveira
Affilliation
Universidade Federal do Ceará. Fortaleza, CE, Brasil.
Croda do Brasil LTDA. Campinas, SP, Brasil.
Universidade Federal do Ceará. Fortaleza, CE, Brasil.
Universidade Federal do Ceará. Fortaleza, CE, Brasil.
Keywords in Portuguese
Imunolipossoma
Oxaliplatina
Câncer colorretal
 
Keywords
Immunoliposome
Oxaliplatin
Colorectal cancer
Colorectal Neoplasms
 
DeCS
Oxaliplatina
Neoplasias Colorretais
 
Citation
MOREIRA, T. da S.; MARQUES, L. P.; PETRILLI, R.; ELOY, J. de O. Development of liposomes conjugated to anti-EGFR monoclonal antibody for selective delivery of oxaliplatin to colorectal cancer cells. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 9., 2025. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2025. p. 65.
DOI
10.35259/isi.2025_69957
Notes
O item foi submetido ao 9th International Symposium on Immunobiologicals 2025 do Instituto de Tecnologia em Imunobiológicos.